Table A6.

HPV-FRAME reporting standards for models of HPV-associated cancers among individuals living with HIV (ILWH).^∗

a) Inputs	Reported? (Y/N)	Report by age? (Y/N)	Report by sex? Y/N (B, M, F)
HPV prevalence, CIN prevalence and cervical cancer incidence by HIV status	Y	Y	Y (implicitly)
HPV disease multipliers on HPV acquisition, progression from HPV infection to cancer (or relevant precursors, if modelled) for HIV-infected women/men	Y	If applicable	Y (implicitly)
HPV-associated cancer mortality by HIV status (and CD4 count if modelled)	Y	Y	Y
Relevant co-morbidities	Y	N	Y
HPV-associated screening sensitivity/specificity by HIV status	Y	If applicable	Y (implicitly)
b) Outputs
Reduction in cervical cancer incidence over time by HIV status (and CD4 count and ART status if modelled)	Y	Y	Y (implicitly)

ART: Antiretroviral therapy; CIN: cervical intraepithelial neoplasia; CD4: CD4 T lymphocytes; HIV: human immunodefiency virus; N: no; Y: yes.

^∗HPV-FRAME core reporting standards are also applicable.